Aiste McCormick

Resecting Beyond the Central Pelvic Compartment in Pelvic Exenterations for Gynaecological Malignancies: Outcomes From a Tertiary Unit

Chia Yew Kong, Norman Galbraith, Aiste McCormick, Michael J. H. Ratcliffe et autres

gb (code pays fourni par la source)

Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022–March 2023)

Neil Ryan, Adam Naskretski, Craig L. Anderson, Lorena Mihaita et autres

gb, ie (code pays fourni par la source)

Review of enhanced breast screening for BRCA carriers with a history of ovarian cancer

Emma Bewick, James Mansell, Aiste McCormick

gb (code pays fourni par la source)

EV189/#1303 Uptake of testing and risk reduction surgery/screening by relatives of ovarian cancer patients identified to carry pathogenic mutations in BRIP1, RAD51C or RAD51D

Aiste McCormick, Nouf Aldhelaan, Lewis Bickett, R M Lindsay et autres

Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer

Samuel Oxley, Sarah Ahmed, Kathryn Baxter, Dominic Blake et autres

gb (code pays fourni par la source)

Correction: Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O’Sullivan et autres

us (code pays fourni par la source)

#402 Implementation of scottish national ovarian cancer quality performance indicators – the process and the outcomes

Aiste McCormick, Kevin Burton, C. Martín, Mahalakshmi Gurumurthy et autres

gb (code pays fourni par la source)

Data from Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O’Sullivan et autres

Data from Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O’Sullivan et autres

Supplementary Data from Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O’Sullivan et autres

Supplementary Data from Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O’Sullivan et autres

The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome

Thomas D. J. Walker, Zahra Faraahi, Marcus J. Price, Amy Hawarden et autres

gb (code pays fourni par la source)